Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 91.24%-153.38K | -115.48%-779.84K | -102.23%-14.55K | 77.89%-429.62K | 1,192.94%1.07M | -72.34%-1.75M | -328.57%-361.91K | 411.45%652.98K | -555.00%-1.94M | 76.94%-97.96K |
| Net income from continuing operations | -166.39%-7.08M | -1,348.48%-4.95M | 29.44%-1.33M | 92.81%-71.37K | -310.94%-729.48K | -322.83%-2.66M | -57.12%396.71K | -345.78%-1.89M | -714.97%-992.42K | -133.48%-177.52K |
| Operating gains losses | -297.93%-778.81K | 99.10%-6.41K | -120.50%-285.01K | -4,552.59%-733.11K | 192.20%245.72K | 111.41%393.48K | 57.11%-714.54K | 1,249.07%1.39M | 97.93%-15.76K | 70.33%-266.51K |
| Depreciation and amortization | -1.41%2.36M | -20.47%490.1K | -48.23%476.39K | -0.01%648.02K | 260.56%742.13K | 269.05%2.39M | 170.71%616.26K | 326.91%920.19K | 218.14%648.08K | 25,468.70%205.83K |
| Asset impairment expenditure | --4.18M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | -205.31%-98.16K | -798.30%-102.45K | -94.03%1.96K | -144.65%-14.05K | 14.98%16.39K | -13.61%93.21K | -86.40%14.67K | --32.82K | --31.47K | --14.25K |
| Remuneration paid in stock | 98.22%194.37K | 49.43%50.98K | -33.61%14.5K | 170.45%65.2K | 254.02%63.69K | -50.70%98.06K | -31.95%34.12K | -56.43%21.84K | -51.38%24.11K | -63.32%17.99K |
| Other non cashItems | 114.75%197.28K | -50.30%51.86K | 390.72%106.04K | 101.69%24.19K | -47.93%15.2K | -1,512.91%-1.34M | 52.53%104.34K | -365.96%-36.47K | -11,661.09%-1.43M | 24,032.23%29.2K |
| Change In working capital | 220.81%880.01K | 39.63%-491.07K | 375.96%1M | -70.48%-348.5K | 809.90%716.98K | -483.50%-728.44K | -501.85%-813.47K | 282.35%210.65K | -622.92%-204.42K | 173.87%78.8K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 91.24%-153.38K | -115.48%-779.84K | -102.23%-14.55K | 77.89%-429.62K | 1,192.94%1.07M | -72.34%-1.75M | -328.57%-361.91K | 411.45%652.98K | -555.00%-1.94M | 76.94%-97.96K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -860.26%-6.92M | -35.73%-257.37K | 74.16%-154.26K | -3,932.05%-2.53M | -8,287,395.83%-3.98M | 80.00%-720.6K | 86.84%-189.62K | -41,211.63%-596.95K | 103.35%66.02K | 99.97%-48 |
| Capital expenditure reported | -787.50%-6.03M | 1,040.35%680.55K | 74.16%-154.22K | -7,263.04%-787.48K | ---5.77M | -3,547.00%-679.95K | -3,259.89%-72.37K | -42,656.45%-596.88K | -686.40%-10.7K | --0 |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | ---- | 36.07%-1.31M | -2,558.34%-60.05K | --0 | 37.81%-1.25M | --0 |
| Interest received (cash flow from investment activities) | 24.90%-193 | 61.64%-28 | 43.84%-41 | 15.87%-53 | -47.92%-71 | -62.66%-257 | -48.98%-73 | -48.98%-73 | -61.54%-63 | -118.18%-48 |
| Net other investing changes | -169.51%-884.92K | -1,541.82%-937.89K | ---- | -231.00%-1.74M | --1.8M | 183.25%1.27M | 96.02%-57.13K | ---- | 2,925.99%1.33M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -860.26%-6.92M | -35.73%-257.37K | 74.16%-154.26K | -3,932.05%-2.53M | -8,287,395.83%-3.98M | 80.00%-720.6K | 86.84%-189.62K | -41,211.63%-596.95K | 103.35%66.02K | 99.97%-48 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.48%58.54K | -100.95%-86.66K | -188.73%-85.19K | -103.66%-85.09K | 997.38%315.48K | 717.27%11.36M | 554.55%9.1M | -29.51K | 2.33M | -35.16K |
| Net issuance payments of debt | -137.92%-380.68K | 26.75%-86.66K | 24.34%-85.19K | -106.89%-85.09K | ---123.73K | --1M | ---118.31K | ---112.61K | --1.23M | --0 |
| Net common stock issuance | --0 | --0 | --0 | --0 | ---- | 716.01%10.11M | 627.87%9.02M | --0 | --1.09M | ---- |
| Proceeds from stock option exercised by employees | 31.71%476.47K | --0 | --0 | --0 | --476.47K | --361.76K | --256.16K | --105.6K | --0 | --0 |
| Net other financing activities | 67.32%-37.25K | --0 | ---- | ---- | -5.96%-37.25K | -175.37%-113.99K | ---56.34K | ---22.5K | ---- | ---35.16K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.48%58.54K | -100.95%-86.66K | -188.73%-85.19K | -103.66%-85.09K | 997.38%315.48K | 717.27%11.36M | 554.55%9.1M | ---29.51K | --2.33M | ---35.16K |
| Net cash flow | ||||||||||
| Beginning cash position | 3,591.51%9.14M | 450.01%3.25M | 520.90%3.5M | 5,622.80%6.55M | 3,591.51%9.14M | -92.88%247.57K | 54.23%590.58K | -5.04%564.06K | -96.00%114.4K | -92.88%247.57K |
| Current changes in cash | -178.89%-7.01M | -113.15%-1.12M | -1,057.88%-254K | -777.13%-3.04M | -1,846.40%-2.59M | 375.47%8.89M | 6,415.23%8.55M | 112.56%26.52K | 119.81%449.66K | 78.23%-133.16K |
| End cash Position | -76.75%2.12M | -76.75%2.12M | 450.01%3.25M | 520.90%3.5M | 5,622.80%6.55M | 3,591.51%9.14M | 3,591.51%9.14M | 54.23%590.58K | -5.04%564.06K | -96.00%114.4K |
| Free cash from | -65.30%-6.19M | 79.91%-99.3K | -400.85%-168.77K | 62.05%-1.22M | -4,700.75%-4.7M | -8.49%-3.74M | -456.31%-494.33K | 126.58%56.1K | -19.88%-3.21M | 79.38%-97.96K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.